A Study to Evaluate the Efficacy and Safety of Radion™-Pdt in Patients With Oral Precancerous Lesion

NCT03279744 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythroleukoplakia of Mouth
Verrucous Hyperplasia of Oral Mucosa

Interventions

DRUG: Radion™-pdt

Sponsor

Pharma Power Biotec Co., Ltd.